Evidence map›Paper›PMID 36656625›Full record

ArticleJournal of medical Internet research2023

Wearable Artificial Intelligence for Anxiety and Depression: Scoping Review.

Alaa Abd-Alrazaq, Rawan AlSaad, Sarah Aziz, Arfan Ahmed, Kerstin Denecke, Mowafa Househ, Faisal Farooq, Javaid Sheikh

Erratum issuedAbstract readScoping Review
In one paragraph

Article in Journal of medical Internet research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Alaa Abd-AlrazaqAI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar.ORCID 0000-0001-7695-4626
Rawan AlSaadAI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar.ORCID 0000-0002-3235-0860
Sarah AzizAI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar.ORCID 0000-0002-0861-9743
Arfan AhmedAI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar.ORCID 0000-0002-4025-5767
Kerstin DeneckeInstitute for Medical Informatics, Bern University of Applied Science, Bern, Switzerland.ORCID 0000-0001-6691-396X
Mowafa HousehDivision of Information and Computing Technology, College of Science and Engineering, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar.ORCID 0000-0002-3648-6271
Faisal FarooqQatar Computing Research Institute, Hamad bin Khalifa University, Doha, Qatar.ORCID 0000-0002-3551-7371
Javaid SheikhAI Center for Precision Health, Weill Cornell Medicine-Qatar, Doha, Qatar.ORCID 0000-0002-5762-4186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnxiety and depression are the most common mental disorders worldwide. Owing to the lack of psychiatrists around the world, the incorporation of artificial intelligence (AI) into wearable devices (wearable AI) has been exploited to provide mental health services.

objectiveThis review aimed to explore the features of wearable AI used for anxiety and depression to identify application areas and open research issues.

methodsWe searched 8 electronic databases (MEDLINE, PsycINFO, Embase, CINAHL, IEEE Xplore, ACM Digital Library, Scopus, and Google Scholar) and included studies that met the inclusion criteria. Then, we checked the studies that cited the included studies and screened studies that were cited by the included studies. The study selection and data extraction were carried out by 2 reviewers independently. The extracted data were aggregated and summarized using narrative synthesis.

resultsOf the 1203 studies identified, 69 (5.74%) were included in this review. Approximately, two-thirds of the studies used wearable AI for depression, whereas the remaining studies used it for anxiety. The most frequent application of wearable AI was in diagnosing anxiety and depression; however, none of the studies used it for treatment purposes. Most studies targeted individuals aged between 18 and 65 years. The most common wearable device used in the studies was Actiwatch AW4 (Cambridge Neurotechnology Ltd). Wrist-worn devices were the most common type of wearable device in the studies. The most commonly used category of data for model development was physical activity data, followed by sleep data and heart rate data. The most frequently used data set from open sources was Depresjon. The most commonly used algorithm was random forest, followed by support vector machine.

conclusionsWearable AI can offer great promise in providing mental health services related to anxiety and depression. Wearable AI can be used by individuals for the prescreening assessment of anxiety and depression. Further reviews are needed to statistically synthesize the studies' results related to the performance and effectiveness of wearable AI. Given its potential, technology companies should invest more in wearable AI for the treatment of anxiety and depression.

Indexed as

Artificial IntelligenceDepressionAdolescentAdultAgedAlgorithmsAnxietyAnxiety DisordersHumansMiddle AgedYoung Adultanxietyartificial intelligencedepressionmobile phonescoping reviewwearable artificial intelligencewearable devices

Identifiers

PMID36656625
PMCPMC9896355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.